Don't Wait on FDA for Social Media Guidance
By Mari Serebrov
Thursday, April 7, 2011
WASHINGTON Everybody's doing it, even the FDA. Using social media, that is. But the online community can be hostile territory for biopharma as the FDA has provided little guidance on where drugmakers can go and what they can do in this 21st century neighborhood.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.